Skip to Main Content

Author Details

Charlotte K Y Ng
University of Bern
2009
144
51
PMIDPaper TitleJournal TitlePublished Year
36124685Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumors.Neuro Oncol2023
37568867Investigation of Different Library Preparation and Tissue of Origin Deconvolution Methods for Urine and Plasma cfDNA Methylome Analysis.Diagnostics (Basel)2023
37294349PI3K inhibition circumvents resistance to SHP2 blockade in metastatic triple-negative breast cancer.J Mammary Gland Biol Neoplasia2023
36749655DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.Cancer Res2023
36796655PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data.Genomics2023
34863035Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma.Mol Oncol2022
35508466Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.Nat Commun2022
35504881Alterations in homologous recombination repair genes in prostate cancer brain metastases.Nat Commun2022
35603298Genomic analysis of focal nodular hyperplasia with associated hepatocellular carcinoma unveils its malignant potential: a case report.Commun Med (Lond)2022
35787660Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers.Commun Biol2022
35814741The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective.Front Med (Lausanne)2022
36517508Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens.Nat Commun2022
36400009Transcription factors TEAD2 and E2A globally repress acetyl-CoA synthesis to promote tumorigenesis.Mol Cell2022
36211376Siglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities.Front Immunol2022
36067230Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model.PLoS Comput Biol2022
35083141Standardizing Patient-Derived Organoid Generation Workflow to Avoid Microbial Contamination From Colorectal Cancer Tissues.Front Oncol2022
35263170Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.JCO Precis Oncol2022
34313788Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens.Nucleic Acids Res2021
33602919Patient-derived xenografts and organoids model therapy response in prostate cancer.Nat Commun2021
33734917Nestin and CD34 expression in colorectal cancer predicts improved overall survival.Acta Oncol2021
33754045Adenylosuccinate lyase is oncogenic in colorectal cancer by causing mitochondrial dysfunction and independent activation of NRF2 and mTOR-MYC-axis.Theranostics2021
33860124Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.Hepatol Commun2021
34712603The Genomic Landscape of Serrated Lesion of the Colorectum: Similarities and Differences With Tubular and Tubulovillous Adenomas.Front Oncol2021
34385466Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses.Nat Commun2021
34348664Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.BMC Genomics2021
34012793Genomic evolutionary trajectory of metastatic squamous cell carcinoma of the lung.Transl Lung Cancer Res2021
32407542Discovery of heterozygous KRT10 alterations in MAUIE cases underlines the importance of regular skin cancer screening in ichthyosis with confetti.Br J Dermatol2020
33137577Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing.Lung Cancer2020
32733792High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes.Front Oncol2020
32650988Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study.Clin Breast Cancer2020
32839156Infiltration by IL22-Producing T Cells Promotes Neutrophil Recruitment and Predicts Favorable Clinical Outcome in Human Colorectal Cancer.Cancer Immunol Res2020
32438307Corrigendum to "HMGA1 expression in human hepatocellular carcinoma correlates with poor prognosis and promotes tumor growth and migration in in vitro models" [Neoplasia 18 (2016) 724-731].Neoplasia2020
30470624Fibroepithelial Breast Lesion: When Sequencing Can Help to Make a Clinical Decision. A Case Report.Clin Breast Cancer2019
31842810Preoperative plasma fatty acid metabolites inform risk of prostate cancer progression and may be used for personalized patient stratification.BMC Cancer2019
31848340LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.Nat Commun2019
32914032Radiogenomics Analysis of Intratumor Heterogeneity in a Patient With High-Grade Serous Ovarian Cancer.JCO Precis Oncol2019
30185420Lobular Carcinomas <i>In Situ</i> Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.Clin Cancer Res2019
31267330Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer.Breast Cancer Res Treat2019
31229654PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform.J Mol Diagn2019
31572728Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.Front Med (Lausanne)2019
31396514Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients.Front Med (Lausanne)2019
31308536Author Correction: Genomic characterization of metastatic breast cancers.Nature2019
31334445Hepatocellular Carcinoma Xenografts Established From Needle Biopsies Preserve the Characteristics of the Originating Tumors.Hepatol Commun2019
30946933The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement.Hum Pathol2019
31118521Genomic characterization of metastatic breast cancers.Nature2019
30745464Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer.Mol Cancer Res2019
30649385The Genomic Landscape of Mucinous Breast Cancer.J Natl Cancer Inst2019
30621641Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer.BMC Cancer2019
28921573Contralateral breast cancers: Independent cancers or metastases?Int J Cancer2018
29975246The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.Am J Surg Pathol2018
  • 1 - 50 of 144

Recommended Authors

Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 3
Sahil Seth
The University of Texas MD Anderson Cancer Center
Career Start Year 2014
Number of shared co-authors 18
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 11
Arshi Arora
Memorial Sloan Kettering Cancer Center
Career Start Year 2011
Number of shared co-authors 11
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 19
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 29
Francisco Beca
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 12
Oscar Krijgsman
The Netherlands Cancer Institute
Career Start Year 2008
Number of shared co-authors 4
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 31
Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2005
Number of shared co-authors 13
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 3
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 24
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 14
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 30
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 17
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 22
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 14
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 3
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 1
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Career Start Year 2002
Number of shared co-authors 3
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 18
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 5
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 32
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 1
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 9
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 15
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 7
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 26

Collaborators

Salvatore Piscuoglio
University of Basel
Co-authored papers 100
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 71
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Co-authored papers 68
Felipe C Geyer
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 26
Larry Norton
Memorial Sloan Kettering Cancer Center
Co-authored papers 25
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Co-authored papers 22
Luciano G Martelotto
Monash University
Co-authored papers 21
Kathleen A Burke
Brown University
Co-authored papers 16
Caterina Marchi??
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 14
Rita A Sakr
Universite Libre de Bruxelles
Co-authored papers 12
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers 11
Pier Selenica
Memorial Sloan Kettering Cancer Center
Co-authored papers 10
Tari A King
Co-authored papers 9
Nicola Fusco
IEO European Institute of Oncology IRCCS
Co-authored papers 9
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 8
Ronglai Shen
Co-authored papers 7
Robert A Soslow
Co-authored papers 7
Brian P Rubin
Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic
Co-authored papers 7
Michael F Berger
Co-authored papers 6
Niko Beerenwinkel
ETH Zurich
Co-authored papers 6
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Agnes Viale
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Susanna L Cooke
Institute of Cancer Sciences, University of Glasgow
Co-authored papers 6
Mark A Rubin
University of Bern
Co-authored papers 5
Melissa P Murray
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Co-authored papers 5
Nora Katabi
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Huei-Chi Wen
Co-authored papers 4
Holger Moch
University Hospital Zurich
Co-authored papers 3
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 3
Release 1.2